Interventional treatment options for tricuspid regurgitation associated with cardiac implantable electronic devices are evolving and improving patient management.
This multidisciplinary review provides an overview of disease mechanisms, diagnostics, and treatment algorithms for patients with CIED-related tricuspid regurgitation.
Tasa de eventos absoluta: 0% vs 0%
Abstract The role of cardiac implantable electronic device (CIED)-related tricuspid regurgitation (TR) is increasingly recognized as an independent clinical entity. Hence, interventional TR treatment options continuously evolve, surgical risk assessment and peri-operative care improve the management of CIED-related TR, and the role of lead extraction is of high interest. Furthermore, novel surgical and interventional tricuspid valve treatment options are increasingly applied to patients suffering from TR associated with or related to CIEDs. This multidisciplinary review article developed with electrophysiologists, interventional cardiologists, imaging specialists, and cardiac surgeons aims to give an overview of the mechanisms of disease, diagnostics, and proposes treatment algorithms of patients suffering from TR associated with CIED lead(s) or leadless pacemakers.
Andreas et al. (Thu,) reported a other. Interventional treatment options for tricuspid regurgitation associated with cardiac implantable electronic devices are evolving and improving patient management.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: